The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
REMINET: A European, multicentre, PHASE II/III randomized double-blind, placebo-controlled study evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours.
 
Come Lepage
Research Funding - Ipsen (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Ipsen
 
Laetitia Dahan
No Relationships to Disclose
 
Jean-Louis Legoux
Honoraria - Novartis
Consulting or Advisory Role - Lilly
Research Funding - Merck Serono (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Celgene; Ipsen; Lilly; Merck Serono; Novartis
 
Karine Le Malicot
No Relationships to Disclose
 
Rosine Guimbaud
Consulting or Advisory Role - Ipsen
Research Funding - Roche (Inst)
 
David Tougeron
No Relationships to Disclose
 
Guillaume Cadiot
Consulting or Advisory Role - Ipsen; Keocyt; Novartis
 
Frédéric Di Fiore
No Relationships to Disclose
 
Denis Michel Smith
Consulting or Advisory Role - Novartis; Pfizer
 
Karine Bouhier Leporrier
No Relationships to Disclose
 
Olivia Hentic
No Relationships to Disclose
 
Astrid Lièvre
No Relationships to Disclose
 
Roger Faroux
No Relationships to Disclose
 
Nadia Bouarioua
No Relationships to Disclose
 
Marianne E. Pavel
Consulting or Advisory Role - Ipsen
 
Ivan Borbath
No Relationships to Disclose
 
Juan W. Valle
Honoraria - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Midatech Pharma; Novartis; Sirtex Medical
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Novartis; Sirtex Medical
Speakers' Bureau - Abbott Nutrition; Celgene; Ipsen; Novartis; Pfizer; Sirtex Medical
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
A Rinke
No Relationships to Disclose
 
Michel Ducreux
No Relationships to Disclose
 
Thomas Walter
No Relationships to Disclose